← Drugs

Local anaesthetic

Local anaesthetics (bupivacaine, lidocaine and others)

Numbing medicines used at the dentist, in surgery and before needles. Their US labels say people with G6PD deficiency are more likely to get a blood problem called methaemoglobinaemia.

Chemical structure of Local anaesthetics (bupivacaine, lidocaine and others): bupivacaine, lidocaine, ropivacaine, drawn by MyGeneLog™ from PubChem records
Chemical structure of bupivacaine, lidocaine, ropivacaine, drawn by MyGeneLog™ from public PubChem records. Free to reuse under CC BY 4.0 with credit to MyGeneLog™.

What this drug connects to

Local anaesthetics (bupivacaine, lidocaine and others) Condition: G6PD Deficiency G6PD Deficiency Condition Variant: rs72554664 · G6PD rs72554664 · G6PD Variant Variant: rs762517 · G6PD rs762517 · G6PD Variant Variant: rs1050828 · G6PD rs1050828 · G6PD Variant Variant: rs1050829 · G6PD rs1050829 · G6PD Variant Variant: rs5945199 · G6PD rs5945199 · G6PD Variant Variant: +1 more +1 more Variant Topic: Blood sugar and insulin Blood sugar and insulin Topic Local anaesthetics (bupivacaine, lidocaine and others) Local anaesthetics (bupivacain… Local anaest…

Solid lines are connections this site curates. Dashed lines mean the two ends share a research paper — worth knowing, and not a claim that one explains the other.

The genes involved

G6PD

G6PD Deficiency →

Numbing medicines such as bupivacaine (Marcaine) and lidocaine can cause methaemoglobinaemia, in which blood carries less oxygen and the skin can look bluish. The Marcaine label says people with G6PD deficiency, or with inherited methaemoglobinaemia, are more likely to show it, and that if a local anaesthetic must be used they should be watched closely. Telling the dentist or surgeon is enough to make that happen.

US prescribing information for MARCAINE (bupivacaine hydrochloride), revised July 2023, section 5.3, Methemoglobinemia; the FDA Table of Pharmacogenomic Biomarkers lists the same row for the other local anaesthetics. A label warning, not the CPIC guideline.

Variants MyGeneLog™ reports for these genes

These are the positions in your own file that carry the genes above. Not every gene in a guideline is one we report — where that is the case the gene appears above without a variant here, and the note says so.

Glycated hemoglobin levels

G6PD · rs72554664

Read more →

Total cholesterol levels

G6PD · rs762517

Read more →

G6PD deficiency (G6PD A-)

G6PD · rs1050828

Read more →

G6PD deficiency (G6PD A+ / A- component)

G6PD · rs1050829

Read more →

Systemic lupus erythematosus

G6PD · rs5945199

Read more →

Hemoglobin levels

G6PD · rs5030868

Read more →

Questions about Local anaesthetics (bupivacaine, lidocaine and others)

What are local anaesthetics?

They are numbing medicines: bupivacaine (Marcaine), lidocaine, ropivacaine and others, given as injections at the dentist or in surgery, or as creams before a needle.

What is methaemoglobinaemia?

It is when too much of the blood's haemoglobin is changed into a form that cannot carry oxygen. The label describes the sign as a bluish skin colour or abnormally coloured blood.

What does G6PD deficiency have to do with it?

The Marcaine label says people with G6PD deficiency, or with inherited methaemoglobinaemia, are more likely to show it. If a local anaesthetic must be used, it asks for close watching for the signs. The FDA lists the same warning for the other local anaesthetics.

Should I tell the dentist?

Yes. If you know you have G6PD deficiency, tell the dentist or surgeon before a numbing injection or cream. It does not usually mean you cannot have one; it means they will watch you more closely.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Local anaesthetics (bupivacaine, lidocaine and others). MyGeneLog™. https://www.mygenelog.com/drugs/local-anaesthetics

This page is educational and contains no dosing information. Where a clinical guideline covers one of these gene-drug pairs it is written for prescribers and works through validated algorithms alongside clinical monitoring. Nothing here is a reason to start, stop, or change a medication — that conversation belongs with the clinician or pharmacist managing your treatment.